Skip to main content
Article thumbnail
Location of Repository

Sensitivities of human monocytes and epithelial cells to pneumolysin are different

By Robert A. Hirst, Hasan Yesilkaya, Edwin Clitheroe, Andrew Rutman, Nicola Dufty, Timothy J. Mitchell, Christopher L. O'Callaghan and Peter W. Andrew


Copyright © 2002, American Society for Microbiology. Also available from the publisher's website at Streptococcus pneumoniae pore-forming toxin, pneumolysin, is an important virulence factor in pneumococcal\ud pneumonia. The effect of pneumolysin on human lung epithelial and monocyte cell viability was compared. Pneumolysin caused a dose-dependent loss of viability of human lung epithelial (A549 and L132)\ud and monocyte (U937 and THP-1) cell lines. Analysis of the dose-response curves revealed similar log 50% inhibitory concentration (pIC50) values for A549, L132, and THP-1 of 0.12 +/-0.1, 0.02 +/-0.04, and 0.12 +/- 0.13 hemolytic units (HU), respectively, but U937 cells showed a significantly greater pIC50 of 0.42 +/- 0.12 HU. Differentiation of A549 and L132 with phorbol ester or THP-1 with gamma interferon had no effect on their sensitivity to pneumolysin. However, a significant decrease in the potency of pneumolysin against U937 cells followed gamma interferon treatment. The Hill slopes of the inhibition curves were greater than unity, indicating that pneumolysin may act with positive cooperativity. Analysis of pneumolysin-treated THP-1 cells by electron microscopy revealed membrane lesions of between 100 and 200 nm in diameter

Publisher: American Society for Microbiology
Year: 2002
OAI identifier:

Suggested articles


  1. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. doi
  2. (1998). Analysis of the IFN-gamma-signalling pathway in macrophages at different stages of development.
  3. (2001). Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin O. doi
  4. (1996). Different sensitivity to streptolysin-O of cells in macrophage lineage. doi
  5. (1989). Expression of the pneumolysin gene in Escherichia coli: rapid purification and biological properties. doi
  6. (1993). Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. doi
  7. (1985). Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. doi
  8. (1997). Origins of cytokine research: the interferon paradigm. doi
  9. (1991). Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. doi
  10. (1994). Pneumolysin stimulates the production of tumor necrosis factor alpha and interleukin-1 by human mononuclear phagocytes.
  11. (1994). Recovery of human fibroblasts from attack by the pore-forming alpha-toxin of Staphylococcus aureus. doi
  12. (1989). Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
  13. (1997). Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia.
  14. (1986). Role of interferon in streptococcal infection doi
  15. (2000). The nature of the high-affinity binding site for staphylococcal alpha toxin: introducing the concept of a quasi receptor.
  16. (1993). Toxicity of pneumolysin to pulmonary alveolar epithelial cells.
  17. (1992). Toxicity of pneumolysin to pulmonary endothelial cells in vitro.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.